⌘K

Login Start Free

Home/Filings/4/0001012975-25-000848

4//SEC Filing

Francis Peter 4

Accession 0001012975-25-000848

CIK 0001808898other

View on SEC.gov Company Profile

Filed

Dec 2, 7:00 PM ET

Accepted

Dec 3, 4:17 PM ET

Size

5.1 KB

Accession

0001012975-25-000848

Insider Transaction Report

Form 4

Period: 2025-12-01

Benitec Biopharma Inc.BNTC

Director

Transactions

Award
Options (right to buy)
2025-12-01+35,000→ 35,000 total
Exercise: $12.23Exp: 2035-12-01→ Common Stock (35,000 underlying)

Footnotes (1)

[F1]The stock options will vest on the earlier of the Issuer's next annual stockholders' meeting or December 1, 2026.

Documents

1 file

4
form4.xmlPrimary
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Issuer

Benitec Biopharma Inc.

CIK 0001808898

Entity typeother

Related Parties

1

filerCIK 0001808850

Filing Metadata

Form type: 4
Filed: Dec 2, 7:00 PM ET
Accepted: Dec 3, 4:17 PM ET
Size: 5.1 KB

View on SEC.gov